The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 07, 2025
Filed:
Feb. 28, 2020
Applicants:
Merrimack Pharmaceuticals, Inc., Cambridge, MA (US);
The Regents of the University of California, Oakland, CA (US);
Inventors:
Yu Zhou, San Francisco, CA (US);
James D. Marks, Kensington, CA (US);
Marco Muda, New Haven, CT (US);
James Frank Sampson, Medford, MA (US);
Eric M. Tam, Cooperstown, NY (US);
Ross Bane Fulton, Southborough, MA (US);
Assignee:
Merrimack Pharmaceuticals, Inc., Massachusetts, MA;
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07K 16/28 (2006.01); A61K 39/395 (2006.01); A61K 47/42 (2017.01); A61P 35/00 (2006.01); A61P 37/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/2878 (2013.01); A61K 47/42 (2013.01); A61P 35/00 (2018.01); A61P 37/00 (2018.01); C07K 2317/24 (2013.01); C07K 2317/52 (2013.01); C07K 2317/732 (2013.01); C07K 2317/75 (2013.01); C07K 2317/92 (2013.01);
Abstract
Disclosed herein are anti-TNFR2 antibodies, therapeutic compositions comprising the anti-TNFR2 antibodies, and methods of using such antibodies and compositions in the treatment of cancer and autoimmune diseases.